Beyond conventional antibiotics - New directions for combination products to combat biofilm

被引:56
作者
Bayramov, Danir Fanisovich [1 ]
Neff, Jennifer Ann [1 ]
机构
[1] Allvivo Vasc Inc, 20914 Bake Pkwy,Suite 100, Lake Forest, CA 92630 USA
基金
美国国家卫生研究院;
关键词
Antimicrobial; Antimicrobial peptides; Antibiotic resistance; Compartment model; Local drug delivery; Medical device coatings; CATIONIC ANTIMICROBIAL PEPTIDES; CENTRAL VENOUS CATHETERS; HOST-DEFENSE PEPTIDES; BLOOD-STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; IN-VITRO; STAPHYLOCOCCUS-AUREUS; MICROBIAL BIOFILMS; RESISTANCE MECHANISMS; GENTAMICIN-RELEASE;
D O I
10.1016/j.addr.2016.07.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medical device related infections are a significant and growing source of morbidity and mortality. Biofilm formation is a common feature of medical device infections that is not effectively prevented or treated by systemic antibiotics. Antimicrobialmedical device combination products provide a pathway for local delivery of antimicrobial therapeutics with the ability to achieve high local concentrations while minimizing systemic side effects. In this review, we present considerations for the design of local antimicrobial delivery systems, which can be facilitated by modeling local pharmacokinetics in the context of the target device application. In addition to the need for local delivery, a critical barrier to progress in the field is the need to incorporate agents effective against bio-film. This article aims to review key properties of antimicrobial peptides that make them well suited to meet the demands of the next generation of antimicrobial medical devices, including broad spectrum activity, rapid and biocidal mechanisms of action, and efficacy against biofilm. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 60
页数:13
相关论文
共 194 条
  • [11] Bayramov D., 2016, FRONT BIOENG BIOTECH
  • [12] Contraceptive devices: subcutaneous delivery systems
    Benagiano, Giuseppe
    Gabelnick, Henry
    Farris, Manuela
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2008, 5 (05) : 623 - 637
  • [13] Berra L, 2006, INTENS CARE MED, V32, P888, DOI 10.1007/s00134-006-0125-6
  • [14] Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
    Boersma, R. S.
    Jie, K. -S. G.
    Verbon, A.
    van Pampus, E. C. M.
    Schouten, H. C.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (03) : 433 - 442
  • [15] Protein antimicrobial barriers to bacterial adhesion: in vitro and in vivo evaluation of nisin-treated implantable materials
    Bower, CK
    Parker, JE
    Higgins, AZ
    Oest, ME
    Wilson, JT
    Valentine, BA
    Bothwell, MK
    McGuire, J
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2002, 25 (01) : 81 - 90
  • [16] Melt extrusion: from process to drug delivery technology
    Breitenbach, J
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) : 107 - 117
  • [17] Therapeutic strategies to combat antibiotic resistance
    Brooks, Benjamin D.
    Brooks, Amanda E.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2014, 78 : 14 - 27
  • [18] Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection
    Bucki, Robert
    Niemirowicz, Katarzyna
    Wnorowska, Urszula
    Byfield, Fitzroy J.
    Piktel, Ewelina
    Watek, Marzena
    Janmey, Paul A.
    Savage, Paul B.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6274 - 6282
  • [19] A review of the biomaterials technologies for infection-resistant surfaces
    Campoccia, Davide
    Montanaro, Lucio
    Arciola, Carla Renata
    [J]. BIOMATERIALS, 2013, 34 (34) : 8533 - 8554
  • [20] Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use
    Campoccia, Davide
    Montanaro, Lucio
    Speziale, Pietro
    Arciola, Carla Renata
    [J]. BIOMATERIALS, 2010, 31 (25) : 6363 - 6377